Loading...
Market
Will the FDA face a new lawsuit challenging mifepristone approval by end of 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA announcements, court filings
Story
U.S. Supreme Court Unanimously Upholds Access to Abortion Pill Mifepristone on June 13, 2024
Jun 13, 2024, 06:53 PM
On June 13, 2024, the U.S. Supreme Court has unanimously upheld access to the FDA-approved abortion pill, mifepristone, rejecting efforts to impose restrictions. This decision preserves access to a medication used in nearly two-thirds of all U.S. abortions. Despite this ruling, the broader fight over abortion rights continues, with some Republicans pushing for nationwide restrictions and bans. The court's decision leaves the FDA's approval of mifepristone intact but does not address future questions about abortion access.
View original story
Similar markets
Yes • 50%
No • 50%
Anti-abortion groups • 33%
Pro-abortion rights groups • 33%
Other • 34%
Yes • 50%
No • 50%
Ninth Circuit • 25%
Fifth Circuit • 25%
DC Circuit • 25%
Other • 25%
California • 25%
Texas • 25%
Florida • 25%
New York • 25%
Increase in support • 33%
Decrease in support • 33%
No significant change • 34%
Texas • 25%
California • 25%
Florida • 25%
New York • 25%